Select Medical (SEM) Reports In-Line Q3 EPS

Select Medical (NYSE: SEM) reported Q3 EPS of $0.20, in-line with the analyst estimate of $0.20. Revenue for the quarter came in at $758.1 million versus the consensus estimate of $750 million.

For earnings history and earnings-related data on Select Medical (SEM) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• TSX movers: VersaBank jumps 10% as corporate catalysts lift top gainers
• Old Dominion Freight Line (ODFL) Reiterated at Buy by Stifel Amid Seasonally Softer Q4/Q1